Get the Stockscreener App
12.18
1.46%
-0.18
Phathom Pharmaceuticals Inc stock is traded at $12.18, with a volume of 600.36K.
It is down -1.46% in the last 24 hours and up +41.30% over the past month.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
See More
Previous Close:
$12.36
Open:
$12.46
24h Volume:
600.36K
Relative Volume:
0.27
Market Cap:
$864.09M
Revenue:
-
Net Income/Loss:
$-297.11M
P/E Ratio:
-2.3468
EPS:
-5.19
Net Cash Flow:
$-216.95M
1W Performance:
+2.27%
1M Performance:
+41.30%
6M Performance:
+111.46%
1Y Performance:
-25.28%
1-Day Range:
$11.78
$12.46
1-Week Range:
$11.42
$12.96
52-Week Range:
$2.21
$19.71
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
Name
Phathom Pharmaceuticals Inc
Sector
Industry
Phone
(877) 742-8466
Address
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Compare PHAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHAT
Phathom Pharmaceuticals Inc
|
12.18 | 876.86M | 0 | -297.11M | -216.95M | -5.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-24 | Initiated | Stifel | Buy |
| Jan-05-24 | Reiterated | Needham | Buy |
| Aug-09-23 | Initiated | H.C. Wainwright | Buy |
| May-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-13-23 | Initiated | Craig Hallum | Buy |
| Oct-21-22 | Initiated | Jefferies | Buy |
| May-06-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-12-21 | Upgrade | Goldman | Sell → Neutral |
| Feb-17-21 | Initiated | BMO Capital Markets | Outperform |
| Feb-02-21 | Initiated | Guggenheim | Buy |
| Jun-26-20 | Downgrade | Goldman | Neutral → Sell |
| Nov-20-19 | Initiated | Evercore ISI | Outperform |
| Nov-19-19 | Initiated | Goldman | Neutral |
| Nov-19-19 | Initiated | Jefferies | Buy |
| Nov-19-19 | Initiated | Needham | Buy |
View All
Phathom Pharmaceuticals Inc Stock (PHAT) Latest News
What the charts say about Phathom Pharmaceuticals Inc. today2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Can a trend reversal in Phathom Pharmaceuticals Inc. lead to recoveryTrade Entry Report & Weekly Momentum Picks - Newser
Published on: 2025-08-31 04:29:11 - Newser
Published on: 2025-08-31 02:28:01 - Newser
Signal strength of Phathom Pharmaceuticals Inc. stock in tech scannersJuly 2025 Decliners & Weekly Top Gainers Alerts - Newser
How hedge fund analytics apply to Phathom Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
Can you recover from losses in Phathom Pharmaceuticals Inc.Trade Risk Summary & Technical Pattern Based Signals - Newser
Why Phathom Pharmaceuticals Inc. is moving todayJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - Newser
Detecting support and resistance levels for Phathom Pharmaceuticals Inc.Share Buyback & Free Expert Approved Momentum Trade Ideas - Newser
Momentum divergence signals in Phathom Pharmaceuticals Inc. chartJuly 2025 Closing Moves & Smart Swing Trading Alerts - Newser
Combining machine learning predictions for Phathom Pharmaceuticals Inc.July 2025 Short Interest & AI Based Buy and Sell Signals - Newser
What makes Phathom Pharmaceuticals Inc. stock price move sharply2025 Key Highlights & High Return Stock Watch Alerts - Newser
Historical volatility pattern of Phathom Pharmaceuticals Inc. visualizedPortfolio Return Summary & Precise Entry and Exit Recommendations - Newser
Phathom Pharmaceuticals Inc. stock retracement – recovery analysisJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Analysts Apply Wyckoff Model to Phathom Pharmaceuticals Inc. Stock getLinesFromResByArray error: size == 0 - thegnnews.com
How to read the order book for Phathom Pharmaceuticals Inc.Earnings Summary Report & High Yield Equity Trading Tips - Newser
What’s next for Phathom Pharmaceuticals Inc. stock priceTrade Analysis Summary & Weekly High Return Stock Opportunities - Newser
Is Phathom Pharmaceuticals Inc. building a consolidation baseCPI Data & Daily Profit Maximizing Tips - Newser
Published on: 2025-08-30 21:32:05 - Newser
How moving averages guide Phathom Pharmaceuticals Inc. tradingMarket Volume Report & Fast Exit/Entry Strategy Plans - Newser
Using data filters to optimize entry into Phathom Pharmaceuticals Inc.Quarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Visual trend scoring systems applied to Phathom Pharmaceuticals Inc.Market Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Chart based analysis of Phathom Pharmaceuticals Inc. trendsChart Signals & Reliable Entry Point Alerts - Newser
Will a bounce in Phathom Pharmaceuticals Inc. offer an exit2025 Pullback Review & Stock Portfolio Risk Management - Newser
Real time breakdown of Phathom Pharmaceuticals Inc. stock performanceEarnings Miss & Smart Money Movement Tracker - Newser
Backtesting results for Phathom Pharmaceuticals Inc. trading strategies2025 Price Momentum & AI Enhanced Trading Alerts - Newser
Phathom Pharmaceuticals Inc Stock (PHAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Phathom Pharmaceuticals Inc Stock (PHAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Topper James N | Director |
May 21 '25 |
Buy |
3.86 |
3,780 |
14,609 |
59,403 |
| Topper James N | Director |
May 14 '25 |
Buy |
3.32 |
6,300 |
20,919 |
55,623 |
| Topper James N | Director |
May 13 '25 |
Buy |
3.16 |
1,120 |
3,543 |
49,323 |
| Topper James N | Director |
May 09 '25 |
Buy |
3.22 |
35,602 |
114,616 |
35,602 |
| Topper James N | Director |
May 12 '25 |
Buy |
3.04 |
12,601 |
38,301 |
48,203 |
| Parikh Asit | Director |
May 06 '25 |
Buy |
2.60 |
5,000 |
13,000 |
90,500 |
| Parikh Asit | Director |
May 07 '25 |
Buy |
2.40 |
5,000 |
11,984 |
95,500 |
| Henderson Molly | CFO and CBO |
Apr 07 '25 |
Sale |
4.55 |
3,678 |
16,740 |
89,868 |
| Parikh Asit | Director |
Sep 10 '24 |
Option Exercise |
11.72 |
7,500 |
87,900 |
93,000 |
| Parikh Asit | Director |
Mar 13 '25 |
Buy |
4.42 |
10,000 |
44,200 |
85,500 |
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):